New Normal Labs ApS: Financial statements 2025
CVR: 39733560
Source: annual report 2025, Danish Business Authority
01/01/2025 – 31/12/2025
New Normal Labs ApS (CVR 39733560) has filed annual accounts for 2025. In 2025, the company reported a gross profit of DKK -1,868 and a net result of DKK -3,283 compared with DKK -7,022 the year before. Equity in the 2025 report amounted to DKK 8,391. The solvency ratio was 3.3%.
- Gross Profit
- DKK -1,868
- Profit/Loss
- DKK -3,283
- Equity
- DKK 8,391
- Total Assets
- DKK 254,321
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2025 | - | -2 t. | -3 t. | 8 t. | - |
| 2024 | - | - | -7 t. | 12 t. | - |
| 2023 | - | -17 t. | -18 t. | 19 t. | - |
| 2022 | - | 33 t. | 32 t. | 36 t. | - |
| 2021 | - | -19 t. | -20 t. | 4 t. | - |
Official annual report
How creditworthy is New Normal Labs ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2025
New Normal Labs ApS has published its annual report for 2024. The net result was DKK -7,022.
About New Normal Labs ApS
New Normal Labs ApS is a Danish company of the type Anpartsselskab based in Birkerød, founded in 2018. The company is registered under the industry Undervisning inden for sport og fritid. The management consists of Martin Kremmer. In 2025, the company reported a gross profit of DKK -1,868 and a net result of DKK -3,283 compared with DKK -7,022 the year before. Equity in the 2025 report amounted to DKK 8,391.